Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

41
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
41

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Survival Analysis of the WSG TP-II Trial: Neoadjuvant Trastuzumab and Pertuzumab Plus Endocrine Therapy Versus Chemotherapy in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Optimizing High-Intensity Functional Training Performance: Individualized Load Prescription vs. Standardized Weights.

Sports (Basel, Switzerland)·2026
Same author

Scan, Screen, Support-A Digital Pathway for Assessing Supportive Care Needs in Oncology: Implementation Study.

JMIR cancer·2026
Same author

From factory floors to dream doors: a systematic review of sleep interventions in industrial workers.

BMC public health·2026
Same author

KEYLYNK-009: Pembrolizumab plus Olaparib in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer after Clinical Benefit from First-Line Pembrolizumab plus Chemotherapy.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Multimodal Artificial Intelligence Model From Baseline Histopathology Adds Prognostic Information for Distant Recurrence Assessment in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.

JCO clinical cancer informatics·2025

Related Experiment Video

Updated: Jul 16, 2025

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.4K

Corrected QT Interval (QTc) Diagnostic App for the Oncological Routine: Development Study.

Kristina Klier1, Yash J Patel2, Timo Schinköthe2,3

  • 1Institute of Sport Science, University of the Bundeswehr Munich, Neubiberg, Germany.

JMIR Cardio
|September 11, 2023
PubMed
Summary

A smartphone app significantly reduced diagnosis time for chemotherapy-induced long QT syndrome (LQTS) by enabling on-site ECGs and tele-cardiologist review. This improves patient care and satisfaction by streamlining monitoring for cardiotoxic side effects.

Keywords:
ECGadverse effectsappapplicationarrhythmiacancercardiologycardiotoxicdiagnosisdiagnosticeHealthelectrocardiographyheartlong QT syndromemHealthmobile healthoncologyprolonged QT intervalside effectstele-cardiologytelehealthtelemedicine

More Related Videos

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
05:39

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

855
Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
06:03

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

6.7K

Related Experiment Videos

Last Updated: Jul 16, 2025

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.4K
Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
05:39

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

855
Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
06:03

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

6.7K

Area of Science:

  • Cardiology
  • Oncology
  • Digital Health

Background:

  • Chemotherapy can cause cardiotoxic side effects, including long QT syndrome (LQTS).
  • Early diagnosis and treatment of LQTS are crucial for preventing fatal outcomes.
  • Routine electrocardiogram (ECG) assessments are vital but can be uncomfortable and require cardiologist support.

Purpose of the Study:

  • To evaluate a smartphone app (QTc Tracker) for efficient and comfortable on-site single-lead ECG recording and tele-cardiologist diagnosis.
  • To assess the impact of the QTc Tracker on workflow efficiency and user satisfaction in cancer centers.

Main Methods:

  • The QTc Tracker was implemented in 54 German cancer centers.
  • 266 corrected QT interval (QTc) diagnoses were recorded for 122 patients.
  • Questionnaires assessed routine ECG workflow, turnaround time, and satisfaction before and after app implementation.

Main Results:

  • The QTc Tracker reduced turnaround time by 98% compared to routine ECG workflows.
  • Combined with an on-call service, time efficiency further improved, with diagnoses in minutes.
  • Nurses and patients reported significantly higher satisfaction with the QTc Tracker, especially patients (1.25 vs. 2.59 satisfaction score).

Conclusions:

  • The QTc Tracker significantly reduces turnaround time and increases user satisfaction for LQTS monitoring.
  • This mobile ECG assessment method offers convenience for patients and physicians, potentially avoiding risks associated with uncontrolled QTc prolongation.
  • Future studies are needed to validate the usability and efficacy of mobile ECG assessment tools in clinical practice.